By THE ASSOCIATED PRESSJAN. 19, 2015
The drug maker AbbVie said on Monday that its new, all-pill hepatitis C combo treatment had been approved for patients in the 28 European Union member countries. AbbVie said the European Commission granted marketing authorization for the treatment combination of Viekirax and Exviera. It was already approved in Switzerland, Norway, Iceland and Liechtenstein, as well as Canada and the United States.A version of this brief appears in print on January 20, 2015, on Page B2 of the New York edition with the headline: European Union Approves Hepatitis C Treatment.  Order Reprints| Today's Paper|Subscribe

Weâ€™re interested in your feedback on this page. Tell us what you think.